KFSHRC secures a US patent to improve breast cancer treatment

King Faisal Specialist Hospital & Research Centre (KFSHRC) has made an advancement in the field of breast cancer treatment and regenerative medicine. The institution recently secured a US patent for an innovative method that transforms ordinary breast cells into multipotent stem cells. This revolutionary technique opens new doors in breast cancer therapies and tissue reconstruction, positioning KFSHRC as a global leader in cutting-edge medical research.

How does it work?

The patented method, developed by KFSHRC researchers Abdelilah Aboussekhra, Huda H. Al-Khalaf, and Hazem Ghebeh, utilizes specialized culture techniques to reprogram regular breast cells into multipotent stem cells. These stem cells possess the ability to regenerate mammary tissue, as demonstrated in animal models.

The findings, published in the Molecular and Cellular Biology journal, highlight the potential for these stem cells to play a pivotal role in personalized breast cancer treatment, offering advanced reconstruction options post-surgery.

Why does it matter?

This innovation is a game-changer for both cancer patients and the broader field of regenerative medicine. By providing personalized reconstruction options, the technique enhances the quality of life for breast cancer survivors.

"KFSHRC's dedication to life-saving therapies reflects their commitment to addressing the needs of cancer patients worldwide," stated the institution.

This aligns with their broader mission to advance patient care through transformative research.

Moreover, KFSHRC's pioneering work in regenerative medicine complements its established leadership in advanced cancer therapies, such as localized CAR T-cell treatments. The hospital's focus on personalized care continues to set new benchmarks in therapeutic outcomes globally.

The context

KFSHRC's achievements extend beyond this patent. The institution has been recognized as the most valuable healthcare brand in the Middle East and ranked first in the region and 20th globally among the top 250 Academic Medical Centres. These accolades, supported by Brand Finance and Newsweek magazine, underscore KFSHRC's role as a trailblazer in medical innovation.

In addition to being ranked among the world's best hospitals, KFSHRC has been named to the World's Best Smart Hospitals list for 2025, further cementing its reputation as a leader in integrating cutting-edge technology with patient care.